Invivyd, Inc. (IVVD)
NASDAQ: IVVD · Real-Time Price · USD
0.7973
-0.0285 (-3.45%)
At close: Sep 9, 2026, 4:00 PM EDT
0.8000
+0.0027 (0.34%)
Pre-market: Sep 10, 2026, 7:41 AM EDT
Invivyd Market Cap
Invivyd has a market cap or net worth of $235.01 million as of September 9, 2026. Its market cap has increased by 3.92% in one year.
Market Cap
235.01M
Enterprise Value
83.32M
1-Year Change
3.92%
Ranking
Category
Stock Price
$0.80
ChartMarket Cap Chart
Since August 6, 2021, Invivyd's market cap has decreased from $2.27B to $235.01M, a decrease of -89.63%. That is a compound annual growth rate of -35.90%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 9, 2026 | 235.01M | -65.67% |
| Dec 31, 2025 | 684.49M | 1,191.45% |
| Dec 31, 2024 | 53.00M | -87.78% |
| Dec 29, 2023 | 433.85M | 165.40% |
| Dec 30, 2022 | 163.47M | -79.76% |
| Dec 31, 2021 | 807.69M | -64.36% |
| Aug 6, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Whitehawk Therapeutics | 255.40M |
| Surrozen | 255.29M |
| Niagen Bioscience | 250.96M |
| Compugen | 246.28M |
| Cellectis | 245.99M |
| Indaptus Therapeutics | 245.17M |
| Eledon Pharmaceuticals | 239.14M |
| Neumora Therapeutics | 238.63M |